位置:首页 > 蛋白库 > VIE2_HCMVA
VIE2_HCMVA
ID   VIE2_HCMVA              Reviewed;         580 AA.
AC   P19893; Q7M6S5;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 2.
DT   23-FEB-2022, entry version 92.
DE   RecName: Full=Viral transcription factor IE2;
DE            Short=IE2;
DE   AltName: Full=Protein UL122;
GN   Name=UL122;
OS   Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5).
OC   Viruses; Duplodnaviria; Heunggongvirae; Peploviricota; Herviviricetes;
OC   Herpesvirales; Herpesviridae; Betaherpesvirinae; Cytomegalovirus.
OX   NCBI_TaxID=10360;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=2161319; DOI=10.1007/978-3-642-74980-3_6;
RA   Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R.,
RA   Horsnell T., Hutchison C.A. III, Kouzarides T., Martignetti J.A.,
RA   Preddie E., Satchwell S.C., Tomlinson P., Weston K.M., Barrell B.G.;
RT   "Analysis of the protein-coding content of the sequence of human
RT   cytomegalovirus strain AD169.";
RL   Curr. Top. Microbiol. Immunol. 154:125-169(1990).
RN   [2]
RP   GENOME REANNOTATION, AND SEQUENCE REVISION.
RX   PubMed=12533697; DOI=10.1099/vir.0.18606-0;
RA   Davison A.J., Dolan A., Akter P., Addison C., Dargan D.J., Alcendor D.J.,
RA   McGeoch D.J., Hayward G.S.;
RT   "The human cytomegalovirus genome revisited: comparison with the chimpanzee
RT   cytomegalovirus genome.";
RL   J. Gen. Virol. 84:17-28(2003).
RN   [3]
RP   ERRATUM OF PUBMED:12533697.
RA   Davison A.J., Dolan A., Akter P., Addison C., Dargan D.J., Alcendor D.J.,
RA   McGeoch D.J., Hayward G.S.;
RL   J. Gen. Virol. 84:1053-1053(2003).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=15452216; DOI=10.1128/jvi.78.20.10960-10966.2004;
RA   Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J.,
RA   Pasa-Tolic L., Wang D., Camp D.G. II, Rodland K., Wiley S., Britt W.,
RA   Shenk T., Smith R.D., Nelson J.A.;
RT   "Identification of proteins in human cytomegalovirus (HCMV) particles: the
RT   HCMV proteome.";
RL   J. Virol. 78:10960-10966(2004).
RN   [5]
RP   ERRATUM OF PUBMED:15452216.
RA   Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J.,
RA   Pasa-Tolic L., Wang D., Camp D.G. II, Rodland K., Wiley S., Britt W.,
RA   Shenk T., Smith R.D., Nelson J.A.;
RL   J. Virol. 78:13395-13395(2004).
RN   [6]
RP   INTERACTION WITH HOST CREB1.
RX   PubMed=7666507; DOI=10.1128/jvi.69.10.6030-6037.1995;
RA   Lang D., Gebert S., Arlt H., Stamminger T.;
RT   "Functional interaction between the human cytomegalovirus 86-kilodalton IE2
RT   protein and the cellular transcription factor CREB.";
RL   J. Virol. 69:6030-6037(1995).
RN   [7]
RP   FUNCTION IN HOST CELL CYCLE MODULATION.
RX   PubMed=10516036; DOI=10.1128/jvi.73.11.9274-9283.1999;
RA   Wiebusch L., Hagemeier C.;
RT   "Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle
RT   progression in G(1).";
RL   J. Virol. 73:9274-9283(1999).
RN   [8]
RP   FUNCTION, SUMOYLATION AT LYS-175 AND LYS-180, AND REGION.
RX   PubMed=19812159; DOI=10.1128/jvi.01525-09;
RA   Berndt A., Hofmann-Winkler H., Tavalai N., Hahn G., Stamminger T.;
RT   "Importance of covalent and noncovalent SUMO interactions with the major
RT   human cytomegalovirus transactivator IE2p86 for viral infection.";
RL   J. Virol. 83:12881-12894(2009).
RN   [9]
RP   INTERACTION WITH HOST TAF12.
RX   PubMed=20519406; DOI=10.1128/jvi.00459-10;
RA   Kim E.T., Kim Y.E., Huh Y.H., Ahn J.H.;
RT   "Role of noncovalent SUMO binding by the human cytomegalovirus IE2
RT   transactivator in lytic growth.";
RL   J. Virol. 84:8111-8123(2010).
RN   [10]
RP   INTERACTION WITH HOST MCM3.
RX   PubMed=20545442; DOI=10.4149/av_2010_02_125;
RA   Song Y.J., Stinski M.F.;
RT   "Human cytomegalovirus IE86 protein binds to cellular Mcm3 protein but does
RT   not inhibit its binding to the Epstein-Barr virus oriP in U373MG-p220.2
RT   cells.";
RL   Acta Virol. 54:125-130(2010).
CC   -!- FUNCTION: Stimulates viral early and late gene expression and thus play
CC       a crucial role in the regulation of productive infection. In addition,
CC       activates quiescent cells to reenter the cell cycle and up-regulates
CC       several E2F-responsive genes, which are responsible for pushing the
CC       cell into S phase. In S-phase, inhibits cellular DNA synthesis and
CC       blocks further cell cycle progression. {ECO:0000269|PubMed:10516036,
CC       ECO:0000269|PubMed:19812159}.
CC   -!- SUBUNIT: Interacts with host SUMO-modified form of TATA-binding protein
CC       (TBP)-associated factor 12/TAF12 in a SIM-dependent manner; this
CC       interaction increases the transactivation activity of IE2. Interacts
CC       with host CHAF1A. Interacts with several components of the host
CC       transcriptional machinery including TBP, TF2B and CREB1. Interacts with
CC       host DNA replication licensing factor MCM3.
CC       {ECO:0000269|PubMed:20519406, ECO:0000269|PubMed:20545442,
CC       ECO:0000269|PubMed:7666507}.
CC   -!- SUBCELLULAR LOCATION: Host nucleus. Note=Colocalizes with host PML-
CC       associated nuclear bodies.
CC   -!- DOMAIN: The SUMO-interacting motif (SIM) is required for efficient
CC       transactivation function. {ECO:0000269|PubMed:19812159}.
CC   -!- PTM: Sumoylated. The sumoylation is necessary for efficient replication
CC       of the virus and thus for the function of this viral transcription
CC       factor. {ECO:0000269|PubMed:19812159}.
CC   -!- SIMILARITY: Belongs to the HHV-5 IE2 protein family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA35324.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17403; CAA35324.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; BK000394; DAA00111.1; -; Genomic_DNA.
DR   PIR; S09889; EDBEM4.
DR   PDB; 6K5R; NMR; -; B=195-206.
DR   PDB; 6K5T; NMR; -; B=195-206.
DR   PDBsum; 6K5R; -.
DR   PDBsum; 6K5T; -.
DR   SMR; P19893; -.
DR   ELM; P19893; -.
DR   Proteomes; UP000008991; Genome.
DR   Proteomes; UP000008992; Genome.
DR   GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0039686; P:bidirectional double-stranded viral DNA replication; IDA:UniProtKB.
DR   GO; GO:0039695; P:DNA-templated viral transcription; ISS:UniProtKB.
DR   GO; GO:0039646; P:modulation by virus of host G0/G1 transition checkpoint; IEA:UniProtKB-KW.
DR   GO; GO:0039645; P:modulation by virus of host G1/S transition checkpoint; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR010855; Cytomega_IE1/IE2.
DR   InterPro; IPR005028; Herpes_IE2_3.
DR   Pfam; PF07340; Herpes_IE1; 1.
DR   Pfam; PF03361; Herpes_IE2_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; DNA-binding; Early protein;
KW   G0/G1 host cell cycle checkpoint dysregulation by virus;
KW   G1/S host cell cycle checkpoint dysregulation by virus; Host nucleus;
KW   Host-virus interaction; Isopeptide bond; Metal-binding;
KW   Modulation of host cell cycle by virus; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..580
FT                   /note="Viral transcription factor IE2"
FT                   /id="PRO_0000115351"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          99..161
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..208
FT                   /note="Non-covalent SUMO1 binding region (SIM)"
FT   REGION          206..335
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..19
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        99..138
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..240
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        255..272
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        306..321
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        175
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:19812159"
FT   CROSSLNK        180
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:19812159"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:6K5R"
SQ   SEQUENCE   580 AA;  62875 MW;  41D1753A02A077ED CRC64;
     MESSAKRKMD PDNPDEGPSS KVPRPETPVT KATTFLQTML RKEVNSQLSL GDPLFPELAE
     ESLKTFEQVT EDCNENPEKD VLAELGDILA QAVNHAGIDS SSTGPTLTTH SCSVSSAPLN
     KPTPTSVAVT NTPLPGASAT PELSPRKKPR KTTRPFKVII KPPVPPAPIM LPLIKQEDIK
     PEPDFTIQYR NKIIDTAGCI VISDSEEEQG EEVETRGATA SSPSTGSGTP RVTSPTHPLS
     QMNHPPLPDP LGRPDEDSSS SSSSSCSSAS DSESESEEMK CSSGGGASVT SSHHGRGGFG
     GAASSSLLSC GHQSSGGAST GPRKKKSKRI SELDNEKVRN IMKDKNTPFC TPNVQTRRGR
     VKIDEVSRMF RNTNRSLEYK NLPFTIPSMH QVLDEAIKAC KTMQVNNKGI QIIYTRNHEV
     KSEVDAVRCR LGTMCNLALS TPFLMEHTMP VTHPPEVAQR TADACNEGVK AAWSLKELHT
     HQLCPRSSDY RNMIIHAATP VDLLGALNLC LPLMQKFPKQ VMVRIFSTNQ GGFMLPIYET
     AAKAYAVGQF EQPTETPPED LDTLSLAIEA AIQDLRNKSQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024